spacer
home > ebr > winter 2019 > the advent of nanoparticle contrast agents
PUBLICATIONS
European Biopharmaceutical Review

The Advent of Nanoparticle Contrast Agents

In the area of cancer alone, molecular imaging of targeted contrast agents is likely to reduce the need for biopsies through cell phenotyping of tumours, enable monitoring to ensure the treatment has reached the target cells or a specific tumour, and, for patient follow-up, quantify the effect of chemotherapy on specific cell types (1). Additionally, nanoparticle contrast agents can be used in pathology specimens to assess tumour heterogeneity without the need for destructive testing. These new methods are likely to have flow-on effects for improving treatment efficiency and introducing personalised treatment plans.

The Rise of Computed Tomography

Computed tomography (CT) is a well-established clinical imaging methodology used to assess disease or injury. In fact, over 300 million CT scans are performed worldwide each year. CT imaging, which produces 3D X-ray images, was originally developed in the 1970s, and speed and resolution have both significantly advanced over the past couple of decades. However, this has now reached a plateau, and further advances in traditional CT are unlikely to have any dramatic clinical benefit.

Traditionally, typical contrast agents for CT have included iodine, barium, and, occasionally, gadolinium. Of these three, iodine has been the predominant contrast agent of choice for CT imaging over the past 40 years. Iodine provides excellent contrast between blood vessels and surrounding tissues and improves the diagnostic quality of CT images. Despite very few changes in contrast agents since the development of CT, the field of CT contrast agents is set for a shakeup with the advent of two new CT technologies that leverage the energy information contained within the X-ray photons. For the first time, dual energy and spectral CT introduce the ability to quantify and separate multiple materials, taking CT from a qualitative imaging modality for structural analysis to a quantitative diagnostic tool. The next generation of CT, with novel contrast agents, will be able to answer questions well beyond the basics of disease location and degree.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Hannah Prebble is a Clinical Applications Researcher at MARS Bioimaging, a manufacturer of preclinical spectral CT systems. Hannah has a PhD in spectral imaging of atherosclerosis, with a focus on imaging of microcalcification, intraplaque haemorrhage, and gold nanoparticles targeted to macrophages. She also holds an MSc in biochemistry and cell biology, with a focus on inflammation in macrophages. Hannah supports a number of researchers in areas varying from bone health and metal implant imaging, through to tumour imaging and soft tissue analysis.
spacer
Dr Hannah Prebble
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Wool packaging firm’s green scheme goes ‘beyond recycling’

An award-winning company that has spent more than 10 years innovating in sustainable packaging has launched a scheme that it says goes ‘beyond recycling’ – by allowing the end user to return their packaging directly to them to be used again.
More info >>

White Papers

Quality of Steel

Natoli Engineering Company, Inc.

Steel quality is the summation of how well a steel meets its specified chemistry, the cleanliness of the steel or degree to which it is free of impurities or inclusion, homogeneity of the microstructure, grain/carbide size and in some instances if it meets the mechanical requirements for that particular steel. In the design and manufacture of tablet compression tooling, nothing is more important than the quality of the materials being used. The best manufacturing principals maintaining the tightest tolerances will result in tool failure if the initial material quality is poor. Material quality is the fundamental building block upon which all successive value added steps are laid. The majority of all tablet compression tooling is produced from steel and steel quality is the subject of this article.
More info >>

 
Industry Events

CPhI Korea

21-23 August 2019, COEX, Seoul, South Korea

CPhI Korea provides a dynamic meeting place for a wide range of industry suppliers to engage with purchasers and decision makers from the pharmaceutical industry in Korea and the surrounding region. The exhibition showcases the whole pharma supply chain from ingredients, contracting services to machinery and biopharmaceuticals. It also hosts an extensive conference programme covering the latest trends and topics within the regional market.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement